NCT05187182 2026-03-18
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Washington University School of Medicine
Phase 1 Recruiting
Washington University School of Medicine
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
University of California, Irvine
Fate Therapeutics
OnKure, Inc.
The Netherlands Cancer Institute